Osaic Holdings’s Assembly Biosciences ASMB Stock Holding History

Osaic Holdings’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75K	Hold	100	–	–	﹤0.01%	7171
2026 Q1	$2.77K	Hold	100	–	–	﹤0.01%	6928
2025 Q4	$3.4K	Hold	100	–	–	﹤0.01%	6889
2025 Q3	$2.56K	Buy	+100	New	+$2.19K	﹤0.01%	7056
2025 Q1	–	Sell	-187	Closed	-$2.95K	–	7440
2024 Q4	$2.95K	Hold	187	–	–	﹤0.01%	6457
2024 Q3	$2.83K	Buy	+187	New	+$2.85K	﹤0.01%	6468
2023 Q4	–	Sell	-42	Closed	-$443	–	7292
2023 Q3	$443	Hold	42	–	–	﹤0.01%	7013
2023 Q2	$575	Hold	42	–	–	﹤0.01%	7021
2023 Q1	$420	Sell	42 -1	-2%	-$17	﹤0.01%	7163
2022 Q4	$1K	Hold	43	–	–	﹤0.01%	6825
2022 Q3	$1K	Hold	43	–	–	﹤0.01%	6931
2022 Q2	$1K	Hold	43	–	–	﹤0.01%	7028
2022 Q1	$1K	Buy	43 +41	+2,050%	+$880	﹤0.01%	6982
2021 Q4	$0	Hold	2	–	–	﹤0.01%	7364
2021 Q3	$0	Sell	2 -3	-60%	-$126	﹤0.01%	7167
2021 Q2	$0	Buy	+5	New	+$248	﹤0.01%	6977

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Osaic Holdings's ASMB Position: Q2 2026 in Review

Osaic Holdings held its Assembly Biosciences (ASMB) position steady in Q2 2026 at 100 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #7171.

Osaic Holdings first reported a position in ASMB in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.4K in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Osaic Holdings held 100 shares of Assembly Biosciences worth $2.75K as of Q2 2026.
Osaic Holdings left its Assembly Biosciences share count unchanged in Q2 2026.
Assembly Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7171 holding.
Osaic Holdings first reported a position in Assembly Biosciences in Q2 2021 and has held it in 16 quarters since.
Osaic Holdings's Assembly Biosciences position peaked at $3.4K in Q4 2025.
93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.